3rd Edition Bioproduction of Immunotherapies

For the third consecutive year, MabDesign and  Medicen organize the Bioproduction of Immunotherapies Day, this year dedicated to: « Developability & Quality Control strategies for Immunotherapies », that will be held on September 18th, 2018 in Biocitech, Romainville (Greater Paris Area).

Last year edition, gathered together more than 120 participants from 70 different companies around plenary lectures, B2B meetings and an exposition hall with 16 companies as exhibitors showcasing their latest innovations in the bioproduction field.

This year, the event program includes plenary sessions of scientific presentations, dedicated time to make B2B meetings and an exhibition Hall to showcase services and products. In order to allow the participants of the event to develop their network, to set up new collaborations and to meet new customers, a B2B partnering platform is available online before the event to set-up your meetings.

The aim of the day is to:
– bring together the stakeholders working in the bioproduction of immunotherapies,
– learn about the strategies used to increase the productivity and the quality of Immunotherapies bioproduction (developability and QTPP),
– discover all about the strategies of monitoring and quality control in continuous bioprocesses.

For more information and register, please visit : https://bioproduction-immunotherapies.b2match.io/



18 september 2018


102 avenue Gaston Roussel, Romainville


MabDesign & Medicen Paris Region


Participant - member of MabDesign or Medicen : 100 € HT
Participant - not member : 150 € HT
Exhibitor - member of MabDesign or Medicen : 400 € HT
Exhibitor - not member : 500 € HT